Get the latest NAV of Bajaj Finserv Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.
₹9.48
▲0.3%1D
NAV as on 30 May 2025
/per year
Since Inception
▲▼
515 people have invested ₹ 8.2L in Bajaj Finserv Healthcare Fund Direct Growth in the last three months
Fund returns vs Benchmark returns vs Category Average returns as on (30-May-25)
The fund has underperformed the benchmark (Nifty 500) over the last 1Y, 3Y, 5Y time periods.
Calculate SIP and lumpsum returns based on historical performance
Total Investment
0
Profit
Total Corpus
0
See fund asset allocation details as on (13-May-25)
Fund Distribution
as on (13-May-25)
Equity 93.2%
Debt & Cash 6.8%
See fund sector allocation details as on (13-May-25)
Sector Allocation
Equity 93.2%
Debt & Cash 6.8%
as on (31-May-25)
Equity
Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.
Expense ratio | 0.67% |
Benchmark | BSE Healthcare TR INR |
AUM | ₹310 Cr |
Inception Date | 27 December, 2024 |
Min Lumpsum/SIP | ₹500/₹500 |
Exit Load | 1.0% |
Lock In | No Lock-in |
TurnOver | 0% |
STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
Risk | Very High Risk |
Bajaj Finserv Healthcare Fund Direct Growth is an equity fund. This fund was started on 27 December, 2024. The fund is managed by Sorbh Gupta, Siddharth Chaudhary. The fund could potentially beat inflation in the long-run.
Bajaj Finserv Healthcare Fund Direct Growth has given a CAGR return of -5.17% since inception.
Bajaj Finserv Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Consumer Defensive, Basic Materials. Its top holdings are Divi's Laboratories Ltd, Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Apollo Hospitals Enterprise Ltd, Piramal Pharma Ltd
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Minimum investment for lump sum payment is INR 500.00 and for SIP is INR 500.00. Bajaj Finserv Healthcare Fund Direct Growth has no lock in period.
Fund Manager of Bajaj Finserv Healthcare Fund Direct Growth, since 27 December 2024
Fund Manager of Bajaj Finserv Healthcare Fund Direct Growth, since 27 December 2024
1Y CAGR
▲ 14.33
1Y CAGR
▲ 12.21